U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984250) titled 'Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer' on April 30.
Brief Summary: Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy
Study Start Date: Feb. 06
Study Type: OBSERVATIONAL
Condition:
Early Breast Cancer
Ductal Breast Carcinoma In Situ
Intervention:
RADIATION: Hypofractionated Radiation Therapy
Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost
Recruitm...